Alliance Pharma PLC TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (4667R)
December 09 2016 - 6:45AM
UK Regulatory
TIDMAPH TIDMAV.
RNS Number : 4667R
Alliance Pharma PLC
09 December 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Alliance Pharma plc
the underlying issuer
of existing shares to which
voting rights are
attached:
--------------------------------------------------------------- -------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------- ---------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
------------------------------------------------------------------- ---------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
------------------------------------------------------------------- ---------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------- ---------------------------------------
Other (please
specify):
----------------------------------------------------------- ------ ---------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
------------------------------------------------------------- ---------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):
Available on request 18,450*
BNY Norwich Union Nominees
Limited 2,682,600*
Chase (GA Group) Nominees
Limited 39,403,058*
*denotes direct interest
Chase Nominees Limited 1,361,894
------------------------------------------------------------- ---------------------------------------------
5. Date of the transaction 6 December 2016
and date on
which the threshold is
crossed or
reached:
------------------------------------------------------------- ---------------------------------------------
6. Date on which issuer 8 December 2016
notified:
------------------------------------------------------------- ---------------------------------------------
7. Threshold(s) that is/are 9% to 8% Change at Direct
crossed or Interest Level (Box 8A & 8B)
reached:
------------------------------------------------------------- ---------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
----------------- ------------------------------ -----------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights
Shares Voting
Rights
----------------- ---------------- ------------ ------------- ------------------------ ------------------
Direct Direct Indirect Direct Indirect
----------------- ---------------- ------------ ------------- ----------- ----------- ------- ---------
Ordinary
Shares
GB0031030819 44,241,981* 44,241,981* 43,466,002 42,104,108 1,361,894 8.92% 0.29%
---------------- ------------ ------------- ----------- ----------- ------- ---------
* Includes Right to Recall Loaned Shares (108,293)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument Period may be
acquired if
the
instrument
is
exercised/
converted.
----------------- ---------------- --------------------------- ------------------------ ------------------
108,293*
RIGHT TO RECALL
LOANED SHARES N/A N/A *Direct Interest 0.02%
----------------- ---------------- --------------------------- ------------------------ ------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights
period refers to
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
43,574,295 9.23%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
Proxy Voting:
--------------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
-------------------------------------------------- ----------------------------------------
11. Number of voting rights proxy
holder will cease to hold:
-------------------------------------------------- ----------------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
-------------------------------------------------- ----------------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
471,983,986, as per the Company's
Exercise of Share Options announcement
of 23(rd) November 2016.
-------------------------------------------------- ----------------------------------------
14. Contact name: James Clark, Aviva plc
-------------------------------------------------- ----------------------------------------
15. Contact telephone number: 01603 683853
-------------------------------------------------- ----------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFKLFBQLFZFBF
(END) Dow Jones Newswires
December 09, 2016 06:45 ET (11:45 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024
